Cingulate (CINGW) Profit After Tax (2021 - 2026)
Cingulate's (CINGW) quarterly Profit After Tax came in at -$5.9 million in Q2 2026, down 17.8% on a YoY basis from -$7.1 million in Q2 2025, and up 6.42% quarter-over-quarter from -$6.3 million in Q4 2025.
Analysis
Cingulate (CINGW) Profit After Tax (2021 - 2026) Analysis & Trends
Cingulate (CINGW) has reported Profit After Tax for 6 consecutive years, with -$5.9 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Profit After Tax fell 17.8% year-over-year to -$5.9 million; the trailing twelve-month figure through Jun 2026 stood at -$24.5 million (down 27.48% YoY), and the FY2025 full-year result was -$22.4 million, down 35.57% from the prior year.
- Profit After Tax rose to -$5.9 million in Q2 2026 per CINGW's latest filing, from -$6.3 million in the prior quarter.
- Across five years, Profit After Tax topped out at -$3.0 million in Q1 2024 and bottomed at -$7.3 million in Q3 2025.
- Historically, Profit After Tax has averaged -$5.1 million across 5 years, with a median of -$5.0 million in 2025.
- The widest YoY moves for Profit After Tax: up 73.66% in 2022, down 275.1% in 2022.
- Over 5 years, Profit After Tax stood at -$4.6 million in 2022, then slumped by 50.6% to -$6.9 million in 2023, then gained by 10.15% to -$6.2 million in 2024, then dropped by 0.67% to -$6.3 million in 2025, then increased by 6.42% to -$5.9 million in 2026.
- According to Business Quant data, Profit After Tax over the past three periods registered -$5.9 million, -$6.3 million, and -$7.3 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 644.32 Bn | 623.56 Bn | 17.26 Bn | 5.53 Bn |
| 2 | AbbVie | 440.60 Bn | 434.04 Bn | 12.70 Bn | 3.62 Bn |
| 3 | Merck | 365.39 Bn | 358.25 Bn | 12.21 Bn | -1.34 Bn |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn | 3.26 Bn |
| 5 | Pfizer | 159.22 Bn | 147.52 Bn | 10.94 Bn | -248.00 Mn |
| 6 | Sanofi | 52.48 Bn | 45.10 Bn | 10.79 Bn | 438.21 Mn |
| 7 | Revolution Medicines | 44.21 Bn | 44.21 Bn | - | -644.37 Mn |
| 8 | Incyte | 25.34 Bn | 20.81 Bn | 1.57 Bn | 585.61 Mn |
| 9 | United Therapeutics | 21.49 Bn | 18.82 Bn | 683.80 Mn | 333.00 Mn |
| 10 | Cingulate | 100,214.03 | 100,214.03 | - | -5.87 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -5.87 Mn |
| Dec 31, 2025 | -6.27 Mn |
| Sep 30, 2025 | -7.34 Mn |
| Jun 30, 2025 | -4.98 Mn |
| Mar 31, 2025 | -3.85 Mn |
| Dec 31, 2024 | -6.23 Mn |
| Sep 30, 2024 | -4.13 Mn |
| Jun 30, 2024 | -3.23 Mn |
| Mar 31, 2024 | -2.97 Mn |
| Dec 31, 2023 | -6.93 Mn |
| Sep 30, 2023 | -5.98 Mn |
| Jun 30, 2023 | -6.62 Mn |
| Mar 31, 2023 | -4.00 Mn |
| Dec 31, 2022 | -4.60 Mn |
| Sep 30, 2022 | -4.03 Mn |
| Jun 30, 2022 | -4.04 Mn |
| Mar 31, 2022 | -5.00 Mn |
| Dec 31, 2021 | -2.65 Mn |
| Sep 30, 2021 | -15.29 Mn |
| Jun 30, 2021 | -1.43 Mn |